Canaccord Genuity analyst Matt Bottomley maintained a Hold rating on Aurora Cannabis (ACB) yesterday and set a price target of C$2.25. The company’s shares closed last Monday at $1.47, close to its 52-week low of $1.43.
According to TipRanks.com, Bottomley is a 3-star analyst with an average return of 1.9% and a 43.4% success rate. Bottomley covers the Healthcare sector, focusing on stocks such as Harvest Health & Recreation, iAnthus Capital Holdings, and Curaleaf Holdings.
Currently, the analyst consensus on Aurora Cannabis is a Hold with an average price target of $2.35, which is a 64.3% upside from current levels. In a report released today, MKM Partners also upgraded the stock to Hold with a C$1.75 price target.
See today’s analyst top recommended stocks >>
The company has a one-year high of $10.32 and a one-year low of $1.43. Currently, Aurora Cannabis has an average volume of 32.05M.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Aurora Cannabis, Inc. engages in the production, distribution and sale of cannabis products. It also produces and sells indoor cultivation systems and hemp related food products. The company was founded by Terry Booth and Steve Dobler on December 21, 2006 and is headquartered in Edmonton, Canada.
Read More on ACB:
